Oligonucleotide microarrays for studying the effects of Ras signal transduction on the genetic program

Signal Transduction

Volumn 6, Issue 3, 2006, Pages 209-218

  Tchernitsa, Oleg I ^a   Sers, Christine ^a   Geflitter, Anita ^a   Schäfer, Reinhold ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Charité Campus Benjamin Franklin Medical Center   (Germany)

Author keywords

Experimental cancer; Gene regulation; Microarray technology; Ras oncogenes

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FIBROBLAST; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE TARGETING; GENETIC TRANSFECTION; GENETICS; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 33745761775     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200600090     Document Type: Article

References (53)

1. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100: 57-70.
2. G. A. Murphy and C. J. Der (2002) Ras-mediated deregulation of gene expression and contribution to oncogenesis. In Oncogene-Directed Therapies. Ed. Rak, J. W., Humana Press, Totowa NJ (USA), pp. 77-100.
3. Shields, J. M., Pruitt, K., McFall, A., Shaub, A. and Der, C. J. (2000) Understanding Ras: ,it ain't over 'til it's over'. Trends Cell Biol. 10: 147-154.
4. Malumbres, M. and Pellicer, A. (1998) Ras pathways to cell cycle control and cell transformation. Front. Biosci. 3: 887-912.
5. Malumbres, M. and Barbacid, M. (2003) RAS oncogenes: the first 30 years. Nat. Rev. Cancer. 3: 459-465.
6. Downward, J. (1998) Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8: 49-54.
7. Marshall, C. J. (1996) Ras effectors. Current Opinion in Cell Biology 8: 197-204.
8. Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J. and Counter, C. M. (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16: 2045-2057.
9. Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J. and Baldwin, A. S., Jr. (1997) Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272: 24113-24116.
10. Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S. M., Zlobin, A., Osborne, B. A., Gottipati, S., Aster, J. C., Hahn, W. C., Rudolf, M., Siziopikou, K., Kast, W. M. and Miele, L. (2002) Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat. Med. 8: 979-986.
11. Zuber, J., Tchernitsa, O. I., Hinzmann, B., Schmitz, A.-C., Grips, M., Hellriegel, M., Sers, C., Rosenthal, A. and Schäfer, R. (2000) A genome-wide survey of Ras transformation targets. Nat. Genet. 24: 144-152.
12. Brem, R., Certa, U., Neeb, M., Nair, A. P. and Moroni, C. (2001) Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine tumor model. Oncogene 20: 2854-2858.
13. Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M. B., Harpole, D., Lancaster, J. M., Berchuck, A., Olson, J. A., Jr., Marks, J. R., Dressman, H. K., West, M. and Nevins, J. R. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
14. Tchernitsa, O. I., Sers, C., Zuber, J., Hinzmann, B., Grips, M., Schramme, A., Lund, P., Schwendel, A., Rosenthal, A. and Schafer, R. (2004) Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23: 4536-4555.
15. R. Schäfer, O. I. Tchernitsa and C. Sers (2006) Global effects of RAS signaling on the genetic program in mammalian cells. In RAS family GTPases. Ed. Der, C., Springer, Heidelberg (Germany), pp. 169-193.
16. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., Gaasterland, T., Glenisson, P., Holstege, F. C., Kim, I. F., Markowitz, V., Matese, J. C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J. and Vingron, M. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29: 365-371.
17. O. I. Tchernitsa, C. Sers, A. Geflitter and R. Schäfer (2006) Effects of Ras signaling on gene expression analyzed by customized microarrays. In Methods in Enzymology. Eds. Der, C. J., Hall, A., and Balch, W. E., Elsevier, Boston (USA), pp. 373-387.
18. Tusher, V. G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98: 5116-5121.
19. Liu, H. S., Scrable, H., Villaret, D. B., Lieberman, M. A. and Stambrook, P. J. (1992) Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res. 52: 983-989.
20. Schwieger, A., Bauer, L., Hanusch, J., Sers, C., Schafer, R. and Bauer, G. (2001) ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 22: 1385-1392.
21. Cheung, V. G., Morley, M., Aguilar, F., Massimi, A., Kucherlapati, R. and Childs, G. (1999) Making and reading microarrays. Nat. Genet. 21: 15-19.
22. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D. and Lander, E. S. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
23. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van, d., V., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H. and Bernards, R. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347: 1999-2009.
24. Schulze, A., Lehmann, K., Jefferies, H. B. J., McMahon, M. and Downward, J. (2001) Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15: 981-994.
25. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H. and Levine, A. J. (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14: 981-993.
26. Schena, M., Shalon, D., Davis, R. W. and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 370: 467-470.
27. Hsieh, H. B., Fitch, J., White, D., Torres, F., Roy, J., Matusiak, R., Krivacic, B., Kowalski, B., Bruce, R. and Elrod, S. (2004) Ultra-high-throughput microarray generation and liquid dispensing using multiple disposable piezoelectric ejectors. J. Biomol. Screen. 9: 85-94.
28. Ramsay, G. (1998) DNA chips: state-of-the art. Nat. Biotechnol. 16: 40-44.
29. Tan, P. K., Downey, T. J., Spitznagel, E. L., Jr., Xu, P., Fu, D., Dimitrov, D. S., Lempicki, R. A., Raaka, B. M. and Cam, M. C. (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 31: 5676-5684.
30. Bammler, T., Beyer, R. P., Bhattacharya, S., Boorman, G. A., Boyles, A., Bradford, B. U., Bumgarner, R. E., Bushel, P. R., Chaturvedi, K., Choi, D., Cunningham, M. L., Deng, S., Dressman, H. K., Fannin, R. D., Farin, F. M., Freedman, J. H., Fry, R. C., Harper, A., Humble, M. C., Hurban, P., Kavanagh, T. J., Kaufmann, W. K., Kerr, K. F., Jing, L., Lapidus, J. A., Lasarev, M. R., Li, J., Li, Y. J., Lobenhofer, E. K., Lu, X., Malek, R. L., Milton, S., Nagalla, S. R., O'malley, J. P., Palmer, V. S., Pattee, P., Paules, R. S., Perou, C. M., Phillips, K., Qin, L. X., Qiu, Y., Quigley, S. D., Rodland, M., Rusyn, I., Samson, L. D., Schwartz, D. A., Shi, Y., Shin, J. L., Sieber, S. O., Slifer, S., Speer, M. C., Spencer, P. S., Sproles, D. I., Swenberg, J. A., Suk, W. A., Sullivan, R. C., Tian, R., Tennant, R. W., Todd, S. A., Tucker, C. J., Van Houten, B., Weis, B. K., Xuan, S. and Zarbl, H. (2005) Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods 2: 351-356.
31. Irizarry, R. A., Warren, D., Spencer, F., Kim, I. F., Biswal, S., Frank, B. C., Gabrielson, E., Garcia, J. G., Geoghegan, J., Germino, G., Griffin, C., Hilmer, S. C., Hoffman, E., Jedlicka, A. E., Kawasaki, E., Martinez-Murillo, F., Morsberger, L., Lee, H., Petersen, D., Quackenbush, J., Scott, A., Wilson, M., Yang, Y., Ye, S. Q. and Yu, W. (2005) Multiple-laboratory comparison of microarray platforms. Nat. Methods 2: 345-350.
32. Larkin, J. E., Frank, B. C., Gavras, H., Sultana, R. and Quackenbush, J. (2005) Independence and reproducibility across microarray platforms. Nat. Methods 2: 337-344.
33. Bos, J. L. (1989) Ras oncogenes in human cancer: a review. Cancer Res. 49: 4682-4689.
34. Diatchenko, L., Lau, Y.-F., Campbell, A. P., Chenchik, A., Moqadam, F., Huang, B., Lukyanov, S. A., Lukyanov, K. A., Gurskaya, N. D., Sverdlov, E. D. and Siebert, P. D. (1996) Suppression subtractive hybridization: a method for generating differentially regulated or issue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. U.S.A. 93: 6025-6030.
35. Bouez, C., Reynaud, C., Noblesse, E., Thepot, A., Gleyzal, C., Kanitakis, J., Perrier, E., Damour, O. and Sommer, P. (2006) The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin. Cancer Res. 12: 1463-1469.
36. Kenyon, K., Contente, S., Trackman, P. C., Tang, J., Kagan, H. M. and Friedman, R. M. (1991) Lysyl oxidase and rrg messenger RNA. Science 253: 802.
37. Hajnal, A., Klemenz, R. and Schäfer, R. (1993) Upregulation of lysyl oxidase in spontaneous revertants of H-ras transformed rat fibroblasts. Cancer Res. 53: 4670-4675.
38. Jeay, S., Pianetti, S., Kagan, H. M. and Sonenshein, G. E. (2003) Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol. Cell Biol. 23: 2251-2263.
39. Palamakumbura, A. H., Jeay, S., Guo, Y., Pischon, N., Sommer, P., Sonenshein, G. E. and Trackman, P. C. (2004) The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J. Biol. Chem. 279: 40593-40600.
40. Wang, Y., Yu, Q., Cho, A. H., Rondeau, G., Welsh, J., Adamson, E., Mercola, D. and McClelland, M. (2005) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7: 748-760.
41. Robinson, P. N., Arteaga-Solis, E., Baldock, C., Collod-Beroud, G., Booms, P., De Paepe, A., Dietz, H. C., Guo, G., Handford, P. A., Judge, D. P., Kielty, C. M., Loeys, B., Milewicz, D. M., Ney, A., Ramirez, F., Reinhardt, D. P., Tiedemann, K., Whiteman, P. and Godfrey, M. (2006) The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet. DOI 10.1136/jmg.2005. 039669.
42. + and Tsk/Tsk embryonic fibroblasts. Amino Acids DOI 10.1007/s00726-005-0265-y.
43. Liang, P., Averboukh, L., Zhu, W. M. and Pardee, A. B. (1994) Ras activation of genes: Mob-1 as a model. Proc. Natl. Acad. Sci. U.S.A. 91: 12515-12519.
44. Zhang, R., Zhang, H., Zhu, W., Pardee, A. B., Coffey-RJ, J. and Liang, P. (1997) Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Oncogene 14: 1607-1610.
45. Melillo, R. M., Castellone, M. D., Guarino, V., De, F., V., Cirafici, A. M., Salvatore, G., Caiazzo, F., Basolo, F., Giannini, R., Kruhoffer, M., Orntoft, T., Fusco, A. and Santoro, M. (2005) The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J. Clin. Invest. 115: 1068-1081.
46. Kashima, N., Ueohzono, T., Fornace, A. J., Jr. and Ide, T. (1995) Induction of gadd153 gene in G0-specific ts mutant cells at nonpermissive temperature. Exp. Cell Res. 217: 324-328.
47. Kim, S. H., Hwang, C. I., Park, W. Y., Lee, J. H. and Song, Y. S. (2006) GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis DOI 10.1093/carcin/bg1027.
48. Talukder, A. H., Wang, R. A. and Kumar, R. (2002) Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells. Oncogene 21: 4289-4300.
49. Horndasch, M., Lienkamp, S., Springer, E., Schmitt, A., Pavenstadt, H., Walz, G. and Gloy, J. (2006) The C/EBP homologous protein CHOP (GADD153) is an inhibitor of Wnt/TCF signals. Oncogene DOI 10.1038/sj.onc.1209380.
50. Rong, R., Montalbano, J., Jin, W., Zhang, J., Garling, M., Sheikh, M. S. and Huang, Y. (2005) Oncogenic Ras-mediated downregulation of Gadd153/CHOP is required for Ras-induced cellular transformation. Oncogene 24: 4867-4872.
51. Peeper, D. S., Dannenberg, J. H., Douma, S., te, R. H. and Bernards, R. (2001) Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat. Cell Biol. 3: 198-203.
52. Schafer, R., Tchernitsa, O. I., Zuber, J. and Sers, C. (2003) Dissection of signal-regulated transcriptional modules by signaling pathway interference in oncogene-transformed cells. Adv. Enzyme Regul 43: 379-391.
53. Sebolt-Leopold, J. S. and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4: 937-947.